BNP Paribas Asset Management
CLVS

BNP Paribas Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

BNP Paribas Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-141,766
Closed -$6.45M – 962
2018
Q2 		$6.45M Buy
141,766
+43,891
+45% +$2.13M 0.05% 427
2018
Q1 		$5.17M Sell
97,875
-7,809
-7% -$456K 0.04% 478
2017
Q4 		$7.19M Buy
105,684
+2,029
+2% +$142K 0.06% 408
2017
Q3 		$8.54M Buy
103,655
+59,153
+133% +$4.69M 0.07% 372
2017
Q2 		$4.17M Buy
+44,502
New +$2.72M 0.04% 530
2014
Q3 		– Sell
-91,249
Closed -$3.78M – 963
2014
Q2 		$3.78M Buy
91,249
+28,928
+46% +$1.49M 0.03% 523
2014
Q1 		$4.32M Buy
+62,321
New +$4.58M 0.03% 470

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BNP Paribas Asset Management's CLVS Position: Q3 2018 in Review

BNP Paribas Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 141,766 shares — an estimated $6.45M sold.

BNP Paribas Asset Management first reported a position in CLVS in Q1 2014 and held it in 7 quarters. The position peaked at $8.54M in Q3 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • BNP Paribas Asset Management reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • BNP Paribas Asset Management sold 141,766 Clovis Oncology, Inc. shares in Q3 2018, an estimated $6.45M.
  • BNP Paribas Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 7 quarters.
  • BNP Paribas Asset Management's Clovis Oncology, Inc. position peaked at $8.54M in Q3 2017.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on BNP Paribas Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.